COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

Dr. Charles Selden

Dr. Charles Selden

Scientific Review Officer


Division of Basic and Integrative Biological Sciences DBIB
Cell Biology CB
Study Section:
Special Emphasis Panels (SEPs) ZRG1

Dr. Sydney Charles Selden III earned his Ph.D. in experimental pathology at the University of Washington in St. Louis, Missouri. His studies were on endothelial cell growth control. He followed this with a postdoctoral fellowship at the Johns Hopkins University School of Medicine, where he studied the structure and biochemistry of cytoskeletal proteins. Dr. Selden was then a fellow at the Revlon Biotechnology Research Center in Rockville, MD, where he studied vascular cells. He then went on to be an assistant professor at the Wilmer Eye to study retinal neovascularization. Prior to joining CSR, Dr. Selden was a program official, then a review officer, at the National Heart, Lung and Blood Institute. He then served for 15 years as the NIH Extramural Staff Training Officer before joining CSR.